Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes. A model for immunogene therapy of cervical cancer. - Dall,P.; Hekele,A.; Beckmann,M.W.; Bender,H.G.; Herrlich,P.; Ponta,H. (Gyn Oncol, 1997)